Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Int.biotech. (IBT) Share Price

Price 1,020.00p on 13-10-2026 at 18:35:12
Change -45.00p -4.23%
Buy 1,035.00p
Sell 1,020.00p
Last Trade: Sell 551.00 at 1,020.00p
Day's Volume: 65,840
Last Close: 1,020.00p
Open: 1,040.00p
ISIN: GB0004559349
Day's Range 1,020.00p - 1,050.00p
52wk Range: 800.00p - 1,215.00p
Market Capitalisation: £322.86m
VWAP: 1,035.13257p
Shares in Issue: 31.65m

Int.biotech. (IBT) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 551 1,020.00p Uncrossing Trade
16:35:06 - 13-Oct-26
Buy* 5 1,030.00p SI Trade
16:29:14 - 13-Oct-26
Buy* 387 1,026.79p Ordinary
16:21:08 - 13-Oct-26
Sell* 2,026 1,022.386p Ordinary
16:18:14 - 13-Oct-26
Unknown* 301 1,025.00p SI Trade
16:12:57 - 13-Oct-26
Unknown* 449 1,025.00p SI Trade
16:11:57 - 13-Oct-26
Buy* 500 1,026.80p Ordinary
16:11:53 - 13-Oct-26
Unknown* 191 1,025.00p SI Trade
16:10:57 - 13-Oct-26
Buy* 387 1,026.795p Ordinary
16:08:11 - 13-Oct-26
Buy* 36 1,025.00p Automatic Execution
15:59:19 - 13-Oct-26
See more Int.biotech. trades

Int.biotech. (IBT) Share Price History

Time period:
to
Date Open High Low Close Volume
13th Oct 2026 (Tue) 1,040.00 1,050.00 1,020.00 1,020.00 65,840
12th Oct 2026 (Mon) 1,050.00 1,065.00 1,050.00 1,065.00 30,290
9th Oct 2026 (Fri) 1,050.00 1,060.00 1,045.00 1,050.00 50,075
8th Oct 2026 (Thu) 1,040.00 1,050.00 1,025.00 1,030.00 98,918
7th Oct 2026 (Wed) 1,065.00 1,065.00 1,060.00 1,060.00 47,454
6th Oct 2026 (Tue) 1,085.00 1,085.00 1,050.00 1,070.00 94,464
5th Oct 2026 (Mon) 1,080.00 1,085.00 1,065.00 1,065.00 60,696
2nd Oct 2026 (Fri) 1,085.00 1,085.00 1,075.00 1,075.00 49,103
1st Oct 2026 (Thu) 1,105.00 1,105.00 1,090.00 1,090.00 19,146
30th Sep 2026 (Wed) 1,120.00 1,120.00 1,100.00 1,120.00 68,259
29th Sep 2026 (Tue) 1,110.00 1,115.00 1,100.00 1,110.00 82,885
28th Sep 2026 (Mon) 1,090.00 1,110.00 1,090.00 1,110.00 62,490
25th Sep 2026 (Fri) 1,095.00 1,115.00 1,095.00 1,105.00 89,630
24th Sep 2026 (Thu) 1,100.00 1,115.00 1,080.00 1,095.00 129,407
23rd Sep 2026 (Wed) 1,120.00 1,120.00 1,100.00 1,105.00 20,749
22nd Sep 2026 (Tue) 1,105.00 1,120.00 1,105.00 1,120.00 24,307
21st Sep 2026 (Mon) 1,110.00 1,110.00 1,100.00 1,110.00 32,243
18th Sep 2026 (Fri) 1,125.00 1,125.00 1,100.00 1,100.00 69,960
17th Sep 2026 (Thu) 1,110.00 1,125.00 1,095.00 1,125.00 22,543
16th Sep 2026 (Wed) 1,080.00 1,105.00 1,080.00 1,105.00 45,037
15th Sep 2026 (Tue) 1,110.00 1,110.00 1,085.00 1,085.00 29,546
14th Sep 2026 (Mon) 1,095.00 1,120.00 1,095.00 1,120.00 115,604
See more Int.biotech. price history

Int.biotech. (IBT) Regulatory News

Date Source Headline
13th Oct 2026 11:19 am RNS Net Asset Value(s)
12th Oct 2026 10:58 am RNS Net Asset Value(s)
9th Oct 2026 11:44 am RNS Net Asset Value(s)
8th Oct 2026 11:58 am RNS Net Asset Value(s)
7th Oct 2026 11:50 am RNS Net Asset Value(s)
6th Oct 2026 11:25 am RNS Net Asset Value(s)
5th Oct 2026 11:52 am RNS Net Asset Value(s)
2nd Oct 2026 5:28 pm RNS Compliance with Market Abuse Regulation
2nd Oct 2026 12:01 pm RNS Net Asset Value(s)
1st Oct 2026 11:57 am RNS Net Asset Value(s)
See more Int.biotech. regulatory news

Int.biotech. (IBT) Share News

UK dividends calendar - next 7 days

14th Aug 2026 12:57

Read More

UK dividends calendar - next 7 days

16th Jul 2026 14:44

Read More

IBT company Crinetics to be acquired by Vertex for USD10 billion

7th Jul 2026 19:11

(Alliance News) - International Biotechnology Trust PLC on Tuesday said its portfolio company, Crinetics Pharmaceuticals Inc, entered a deal to be acquired by Vertex Pharmaceuticals Inc in a deal worth USD10 billion. Read More

IN BRIEF: International Biotech highlights deal for investee Apogee

22nd Jun 2026 20:07

International Biotechnology Trust PLC - invests in biotechnology companies - Notes announcement that investee company Apogee Therapeutics is to be acquired by AbbVie Inc. Apogee shareholders will receive USD135.11 per share in cash at closing. As at close of business on Friday, Apogee represented around 0.41% of IBT's net asset value. IBT Portfolio Managers Ailsa Craig and Marek Poszepczynski say: "The biotech M&A boom shows no signs of slowing, with deal flow running ahead of last year's pace. The latest deal represents the seventh acquisition within the IBT portfolio in 2026 so far, compared to three acquisitions at the same stage last year, with the total value of the companies acquired also up 9%. This demonstrates the success of our investment strategy." Read More

EARNINGS: Griffin Mining revenue jumps; Andrews Sykes holds payout

12th May 2026 12:48

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

See more Int.biotech. news
FTSE 100 Latest
Value10,650.33
Change-5.95

Login to your account

Forgot Password?

Not Registered